MRNAHealthcareLarge-Cap

Moderna, Inc. Insider Trading Activity

Every SEC Form 4 insider transaction reported for Moderna, Inc. (MRNA), sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Are MRNA insiders buying or selling?

Moderna, Inc. insiders reported 3 open-market buys ($7.0M) and 818 sells ($3.7B) across 821 Form 4 filings — a net selling position of $3.7B.

Source: SEC EDGAR Form 4

Key Statistics (as of Jul 16, 2026)

Total Form 4 filings
821
SEC EDGAR
Insider filers
19
Insider buys (3)
$7.0M
Insider sells (818)
$3.7B

Insider sentiment

Net selling

Net insider flow of $3.7B in net selling.

Recent MRNA insider transactions

DateInsiderRoleTypeSharesPriceValue
Jul 16, 2026Stephen HogePresidentSale53.3K$67.60$3.6M
Jun 17, 2026Stephen HogePresidentSale53.3K$51.37$2.7M
Jun 8, 2026Shannon Thyme KlingerChief Legal OfficerSale3.5K$50.00$173.6K
May 22, 2026Noubar AfeyanDirectorSale9.3K$46.84$433.9K
May 18, 2026Stephen HogePresidentSale53.3K$48.40$2.6M
May 4, 2026Abbas HussainDirectorSale5.7K$46.63$265.0K
Mar 3, 2026Shannon Thyme KlingerChief Legal OfficerSale13.9K$52.29$726.0K
Feb 25, 2026Stephen HogePresidentSale160.0K$48.84$7.8M
Dec 15, 2025Noubar AfeyanDirectorSale23.9K$29.49$703.3K
Dec 11, 2025Abbas HussainDirectorSale504$27.60$13.9K
Jun 12, 2025Abbas HussainDirectorSale312$28.00$8.7K
Mar 4, 2025Stephane BancelChief Executive OfficerPurchase160.3K$31.22$5.0M
Mar 4, 2025Paul SaganDirectorPurchase31.6K$31.76$1.0M
Dec 10, 2024Shannon Thyme KlingerChief Legal OfficerSale529$44.68$23.6K
Dec 4, 2024Shannon Thyme KlingerChief Legal OfficerSale112$43.30$4.8K
Dec 4, 2024Stephen HogePresidentSale314$43.30$13.6K
Dec 2, 2024James M MockChief Financial OfficerSale1.4K$42.79$60.8K
Dec 2, 2024Shannon Thyme KlingerChief Legal OfficerSale1.4K$42.79$60.7K
Dec 2, 2024Stephen HogePresidentSale291$42.79$12.5K
Nov 12, 2024Stephen HogePresidentSale277$46.10$12.8K
Oct 8, 2024James M MockChief Financial OfficerSale715$60.12$43.0K
Sep 10, 2024Shannon Thyme KlingerChief Legal OfficerSale551$73.57$40.5K
Sep 4, 2024Shannon Thyme KlingerChief Legal OfficerSale114$76.99$8.8K
Sep 4, 2024Stephen HogePresidentSale318$76.99$24.5K
Aug 30, 2024James M MockChief Financial OfficerSale162$78.03$12.6K

Showing the 25 most recent of 821 Form 4 filings for Moderna, Inc..

Most active MRNA insiders

  • Stephane Bancel266 filings
  • Juan Andres145 filings
  • Stephen Hoge145 filings
  • Noubar Afeyan86 filings
  • Tal Zvi Zaks73 filings

Ask anything about MRNA insider activity

Use Trabud's AI agent to query Moderna, Inc.'s Form 4 history in plain English — "Show me MRNA CEO purchases this year" or compare it against any other ticker.

Open the AI agent

MRNA insider trading FAQ

Are Moderna, Inc. insiders buying or selling?

Across 821 SEC Form 4 filings, Moderna, Inc. (MRNA) insiders reported 3 open-market purchases totaling $7.0M and 818 sales totaling $3.7B. That is a net selling position of $3.7B.

How many insiders trade MRNA stock?

19 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Moderna, Inc.. The most recent filing was accepted on Jul 16, 2026.

Where does Trabud get MRNA insider trading data?

All MRNA insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Looking for another company? Browse all tracked companies.

Related Content